Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Antioxidant Nanoparticles Neutralize Superoxide and Restore Blood Flow Following Traumatic Brain Injury

By LabMedica International staff writers
Posted on 05 Sep 2012
A novel class of potent antioxidant nanoparticles restores brain blood flow and normalizes superoxide and nitric oxide levels in the brains of a rat model of traumatic brain injury (TBI).

Cerebrovascular dysfunction, manifested by reduction in cerebral blood flow (CBF), is a key factor that worsens outcome after TBI, most notably under conditions of hypotension. More...
In a traumatic brain injury, damaged cells release an excessive amount of the reactive oxygen species (ROS) superoxide (SO) into the blood. Healthy organisms balance SO with increased production of the neutralizing enzyme superoxide dismutase (SOD), but even mild brain trauma can release superoxides at levels that overwhelm the brain’s capacity for SOD synthesis.

Based on data accumulated in studies designed to enhance cancer treatment via nanoparticle-based drug delivery, investigators at Rice University (Houston, TX, USA) decided to test their potential for treating TBI. These poly(ethylene glycol)-functionalized hydrophilic carbon clusters (PEG-HCCs) represent a new class of nontoxic, antioxidant carbon-based nanoparticles.

PEG-HCCs were administered to a mild TBI/hypotension/resuscitation rat model during resuscitation, which is a clinically relevant time point. Results published in the August 6, 2012, online edition of the journal ACS Nano revealed that the particles rapidly restored CBF. Along with restoration of CBF, there was a concomitant normalization of superoxide and nitric oxide levels.

“Superoxide is the most deleterious of the reactive oxygen species, as it is the progenitor of many of the others,” said senior author Dr. James M. Tour, professor of chemistry, mechanical engineering, and materials science at Rice University. “If you do not deal with SO, it forms peroxynitrite and hydrogen peroxide. SO is the upstream precursor to many of the downstream problems. While an SOD enzyme can alter only one superoxide molecule at a time, a single PEG-HCC about the size of a large protein at two to three nanometers wide and 30 to 40 nanometers long can quench hundreds or thousands. This is an occasion where a nano-sized package is doing something that no small drug or protein could do, underscoring the efficacy of active nano-based drugs.”

“This might be a first line of defense against reactive oxygen species (ROS) that are always overstimulated during a medical trauma, whether that be to an accident victim or an injured soldier,” said Dr. Tour. “They are certainly exacerbated when there is trauma with massive blood loss.”

Related Links:
Rice University




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.